The White House Says Boosters for All: Here’s What You Need to Know: “Stick to the advice from the CDC and the FDA, because they are doing their very best to ensure maximum protection and safety”
The Biden administration announced plans Wednesday to offer boosters to all U.S. adults as soon as next month, saying that recent data, including some made available only in the past few days, played a role in that decision.
“If you wait for something bad to happen before you respond to it, you find yourselves considerably behind,” Dr. Anthony Fauci said during a White House briefing. “You want to stay ahead of the virus.”
White House officials emphasized that the rollout of boosters was pending review of evidence by officials at the Food and Drug Administration as well as the advisory committee to the Centers for Disease Control and Prevention.
The rollout would begin the week of Sept. 20. U.S. residents 18 and older who received the Moderna or Pfizer-BioNTech vaccines would be eligible for a third shot eight months after their second dose. The timing would mean that health care workers, long-term care residents and older residents would be first in line for boosters.
“If you are fully vaccinated, you still have a high degree of protection from the worst outcomes — we are not recommending you go out and get a booster today,” U.S. Surgeon General Vivek Murthy said. Johnson & Johnson vaccines were not distributed until March and a plan for those booster shots will come later, officials said.
Political and corporate pressure to offer a booster to U.S. citizens has been mounting over the summer months, as the highly contagious delta variant has spread nationally and filled hospital beds. On Wednesday, Biden officials offered slides filled with charts of recent data, talked about antibody response, and noted that research showing waning vaccine strength in Israel played a key role in their decision as did a study from Mayo Clinic that is not yet peer-reviewed.
“Stick to the advice from the CDC and the FDA, because they are doing their very best to ensure maximum protection and safety,” said Dr. Cody Meissner, a specialist in pediatric infectious diseases who sits on the FDA’s vaccine advisory panel. “People have to be very careful about statements that come from Big Pharma. They have a very different goal.”
Dr. Sadiya Khan, an epidemiologist and cardiologist at Northwestern University’s Feinberg School of Medicine, said that taking any medication has risks and that adding an additional dose of vaccine might cause unnecessary side effects. “What we need is data,” she said.
More Articles
- Women's Labor Force Exits During COVID-19: Differences by Motherhood, Race, and Ethnicity
- GAO Report On Air Travel and Communicable Diseases: Federal Leadership Needed to Advance Research
- Why Some Cities Lost Population in 2021: One Specific Group — Younger Adults in Their Early 20s to Mid-30s
- Justice Department Secures Agreement with CVS Pharmacy, Inc. to Make Online COVID-19 Vaccine Registration Accessible for People with Disabilities
- GAO* Report, Cybersecurity: National Institutes of Health Needs to Take Further Actions to Resolve Control Deficiencies and Improve Its Program
- Stanford Medicine: COVID-19 Vaccine Effective in People Wth Cancer
- Journalist's Resource: Religious Exemptions and Required Vaccines; Examining the Research
- Testimony of Secretary of the Treasury Janet L. Yellen before the Senate Committee on Banking, Housing, and Urban Affairs: "The debt ceiling has been raised or suspended 78 times since 1960"
- Jo Freeman's Review of "Frankly, We Did Win This Election" By Michael C. Bender
- Researchers From Yale University, Stanford Medical School, University of California, Berkeley: Largest Study of Its Kind Finds Face Masks Reduce COVID-19
